1 Apr 2020
CMED TECHNOLOGIES LTD v. PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP (a firm) AND ANOTHER
- Citation
- [2020] HKCFI 567
- Court
- Court of First Instance
- Case number
- HCA3272/2016
Leave to appeal refused because the judge correctly applied the substance test and Spiliada balancing to conclude the tort was in substance committed in Hong Kong, there is no realistic prospect that a novel contention (displacing Hong Kong law by reference to the governing contract or foreign public policy) would succeed, and no error of principle or material fact that justifies appellate intervention.